Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
908 Devices Inc(MASS)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for MASS
10/02/2026: MASS (2-star) has a low Upturn Star Rating. Not recommended to BUY.
908 Devices Inc is a specialized developer of handheld and desktop mass spectrometry devices that bring portable, lab-grade analytical capabilities to the field and bioprocessing environments. The company has a leading position in niche areas like chemical identification for first responders and at-line biopharmaceutical monitoring, driven by its proprietary HPMS technology. Its primary growth opportunity lies in expanding its installed base across the biopharma manufacturing sector. Investors should weigh this potential against significant execution and valuation risks, as the firm is still scaling toward consistent profitability. This stock is generally best suited for growth-oriented investors who can tolerate high volatility and long-term investment horizons.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Strong fit | The company offers exposure to disruptive technology in a high-growth sector. |
| Momentum investor | Mixed fit | This is a conditional play depending on sustained revenue growth signals and market adoption. |
| Value investor | Weak fit | The company is not currently valued based on traditional earnings multiples. |
| Dividend investor | Weak fit | The company does not pay dividends and focuses on reinvesting all capital. |
| Low-risk investor | Weak fit | High price volatility and growth-stage execution risks make this unsuitable for low-risk portfolios. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | High | The stock is susceptible to large swings based on quarterly results and sentiment. |
| Valuation risk | Medium / high | Valuation is often tied to future growth expectations rather than current profitability. |
| Competition risk (Established Analytical Firms) | High | Large competitors could leverage their scale to introduce competing portable technologies. |
| Business quality | Medium | The business has unique technology but is still scaling toward consistent profitability. |
| Dividend income | Low / none | No income is generated for shareholders. |
| Execution risk | Medium / high | The company must successfully scale its commercial operations to realize its full potential. |
Price Behavior
Hockey-Stick Growth
The stock demonstrates a Hockey-Stick Growth price path pattern.
Choppy
The stock has experienced frequent reversals and pronounced short-term price swings.
Analysis of Past Performance
Type Stock | Historic Profit 0.62% | Avg. Invested days 25 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Advisory Rating  | Upturn Advisory Performance  3.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/02/2026 |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals
Financial Health Rating
Growth Momentum Score
Ownership
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue)
Economic Dimensions
Quantitative Style Profile
Style Classification
Quality Focused
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 517.08M USD | Price to earnings Ratio - | 1Y Target Price 13.38 |
Price to earnings Ratio - | 1Y Target Price 13.38 | ||
Volume (30-day avg) 405.5K shares | Beta 0.68 | 52 Weeks Range 5.03 - 12.93 | Updated Date 10/02/2026 |
52 Weeks Range 5.03 - 12.93 | Updated Date 10/02/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.94 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Product Sales | Sale of MX908, Rebel, and ZipChip instruments. | Revenue is primarily driven by the initial sale of specialized analytical equipment. |
| Service and Consumables | Recurring revenue from maintenance contracts, service, and consumable chips. | This creates a predictable stream of revenue that grows as the installed base increases. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Valuation
Trailing PE - | Forward PE - | Enterprise Value 355.37M | Price to Sales(TTM) 8.5 |
Enterprise Value 355.37M | Price to Sales(TTM) 8.5 | ||
Enterprise Value to Revenue 5.84 | Enterprise Value to EBITDA -3.15 | Shares Outstanding 41.33M | Shares Floating 28.08M |
Shares Outstanding 41.33M | Shares Floating 28.08M | ||
Percent Insiders 7.39 | Percent Institutions 83.79 |
Upturn AI Summary
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
About 908 Devices Inc
Exchange NASDAQ | Headquarters Burlington, MA, United States | ||
IPO Launch date 2020-12-18 | Co-Founder, CEO, President & Director Dr. Kevin J. Knopp Ph.D. | ||
Sector Healthcare | Industry Medical Devices | Full time employees 172 | Website https://908devices.com |
Full time employees 172 | Website https://908devices.com | ||
908 Devices Inc. provides purpose-built handheld mass spectrometry and fourier transform infrared (FTIR) devices for use in vital health and safety applications. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; XplorIR, a handheld device that uses FTIR spectroscopy to identify, quantify, and track gases and vapors; ThreatID, a portable FTIR device that rapidly detects and identifies approximately 28,000 unknown gas, vapor, powder, and liquid chemical hazards; ProtectIR, a handheld FTIR device that can identify approximately 23,000 solid and liquid chemical hazards; and VipIR, a handheld 3-in-1 analyzer that integrates FTIR, Raman spectroscopy, and smart spectral processing (SSP), a proprietary algorithm, to provide a single result from just one sample. It operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of Americas. The company was incorporated in 2012 and is headquartered in Burlington, Massachusetts.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.